Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Gale

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Arthritis Care & Research|June 2, 2018
Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid ArthritisJessica C Wilson, Khaled Sarsour, Sara Gale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2017
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort StudySeoyoung C Kim, Daniel H Solomon, James R Rogers, et al.
Seminars in Arthritis and Rheumatism|April 21, 2018
No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort studySeoyoung C Kim, Daniel H Solomon, James R Rogers, et al.
Seminars in Arthritis and Rheumatism|April 11, 2019
Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort studySeoyoung C Kim, Ajinkya Pawar, Rishi J Desai, et al.
Rheumatology and Therapy|February 2, 2019
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims DataSara Gale, Huong Trinh, Katie Tuckwell, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort studyAjinkya Pawar, Rishi J Desai, Daniel H Solomon, et al.
Rheumatology and Therapy|May 13, 2018
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UKSara Gale, Jessica C Wilson, Jenny Chia, et al.
ACR Open Rheumatology|February 12, 2020
Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score DevelopmentJamie E Collins, Fredrik D Johansson, Sara Gale, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Arthritis Care & Research|June 2, 2018
Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid ArthritisJessica C Wilson, Khaled Sarsour, Sara Gale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2017
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort StudySeoyoung C Kim, Daniel H Solomon, James R Rogers, et al.
Seminars in Arthritis and Rheumatism|April 21, 2018
No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort studySeoyoung C Kim, Daniel H Solomon, James R Rogers, et al.
Seminars in Arthritis and Rheumatism|April 11, 2019
Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort studySeoyoung C Kim, Ajinkya Pawar, Rishi J Desai, et al.
Rheumatology and Therapy|February 2, 2019
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims DataSara Gale, Huong Trinh, Katie Tuckwell, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort studyAjinkya Pawar, Rishi J Desai, Daniel H Solomon, et al.
Rheumatology and Therapy|May 13, 2018
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UKSara Gale, Jessica C Wilson, Jenny Chia, et al.
ACR Open Rheumatology|February 12, 2020
Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score DevelopmentJamie E Collins, Fredrik D Johansson, Sara Gale, et al.
Pageof 2